Friday, March 4
**Time is in Eastern Standard Time (EST). Click here to find your local time.
|
| All Day |
- ISOPP Initiatives and Sponsor and Exhibitors Gallery
- Meeting Hub: Connect with colleagues from around the world!
|
| 08:00-08:15 |
Welcome Remarks
|
| 08:15-08:45 |
Networking: Meet and Greet!
|
| 08:45-10:15 |
Opening Plenary - The Patient Experience During COVID-19
Heidi Finnes, USA and Evalyn Allela, Cipla Kenya, Kenya
|
| 10:15-10:45 |
Visit:
- ISOPP Initiatives and Sponsor and Exhibitors Gallery
- Meeting Hub to connect with colleagues from around the world!
|
| 10:45-11:45 |
Sponsored Symposium: BD - Introducing a novel CSTD to protect healthcare workers and a reduce contamination across preparation and administration areas in multisite health system
|
| 11:45-12:15 |
Networking
|
| 12:15-13:00 |
Concurrent Sessions |
|
Extravasation Management: Specific Pharmacological and Non-Pharmacological Measures and Antineoplastic Tissue Risk Classification
María Asunción Albert-Marí, Hospital Universitario y Politecnico La Fe, Spain
|
Immunotherapy Updates in Solid Tumor Malignancies
Jared Borlagdan, Oregon Health and Science University (OHSU), USA
|
Saturday, March 5
**Time is in Eastern Standard Time (EST). Click here to find your local time.
|
All Day
|
- ISOPP Initiatives and Sponsor and Exhibitors Gallery
- Meeting Hub: Connect with colleagues from around the world!
|
| 08:00-09:00 |
Plenary - Can immunotherapy contribute to a vision of precision cancer medicine?
Elaine Vickers, Science Communicated Ltd, UK |
| 09:00-10:00 |
ISOPP Annual General Meeting (AGM)
Strategic Plan and Standards Update
|
| 10:00-10:30 |
Visit:
- ISOPP Initiatives and Sponsor and Exhibitors Gallery
- Meeting Hub to connect with colleagues from around the world!
|
| 10:30-11:30 |
Plenary - Getting the dose right in kidney dysfunction - the International Consensus Guideline on Anticancer Drug Dosing in Kidney Dysfunction (ADDIKD)
Jolanta Małyszko, Poczta Onet, Poland
Michael Michael, Peter MacCallum Cancer Centre, Australia
Geeta Sandhu, Cancer Institute NSW, Australia
Carla Scuderi, Queensland Health, Australia
Ben Sprangers, University Hospitals Leuven, Belgium |
| 11:30-12:30 |
Hot Topic Discussions led by facilitators
- Defining cytotoxic drugs: you know it when you see it? - Mario de Lemos, BC Cancer, Canada
- Clinical trials and the oncology pharmacist – Garbiñe Lizeaga, Hospital Universitario Donostia, Spain
- Experiences and challenges managing cancer patients during the COVID-19 pandemic – Irene Weru, Kenyatta National Hospital, Kenya
- What to do when it’s gone – Tatiana Hales, Alberta Health Services, Canada
- Role of Pharmacist in outpatient clinics - Ada Cheung, Peter MacCallum Cancer Centre, Australia
|
| 12:30-13:15 |
Plenary- Keeping it all in check: immune checkpoint inhibitor dosing
Alison Palumbo, Oregon Health and Science University (OHSU), USA |
| 13:15-13:45 |
Highlights of the Symposium and Closing Remarks |
